本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
SINGAPORE, May 9, 2024 /PRNewswire/ -- The Jia He Rice Dumpling Festival takes place from 9 May 2024 to 10 June 2024. Most would especially celebrate the Year of the Dragon by partaking in the Dragon Boat Festival. Guests are encouraged to participate in the traditional festivity, with a delightful and piping hot steamed assortment of Rice dumplings from Jia He eshop and available for pre orders at Jia He Chinese Restaurant and Jia He Grand. Attempt the newest edition of Rice dumpling flavour. Discover the Taste of Tradition with Jia He's New Sambal Nonya Pork Dumpling with Salted Egg Yolk! Enjoy the favourites from Premium X.O. Braised Pork Dumpling with Chestnut to Butterfly Blue Pea Nonya Minced Meat Dumpling and more. EARLY BIRD PROMO5% off with minimum order of 4 Rice Dumplings from 9 to 26 May 2024.*With Participating Bank Cards, see Jia He website for details. Pre-order is required.Visit https://shop.jiahe.com.sg to place your order soon! *Terms and conditions apply.*Not valid for Jia He Dumplings combo sets. #JiaHeChineseRestaurant #JiaHeRestaurant #JiaHeGrand #JiaHeRiceDumplingFestival#JiaHeRestaurantRiceDumplingFestival == Jia He Chinese Restaurant @ ConnexionFor reservations, please contact 6694 8988 / 6694 9466 Email: enquiries@jiahe.com.sg1 Farrer Park Station Road, #01-14/15/16 Connexion, Singapore 217562 Jia He Grand @ One Farrer HotelFor Reservations, please contact 6538 9688 / 6538 2788 Email: jiahegrand@jiahe.com.sgOne Farrer Hotel, Level 11 Farrer Park Station Rd, Singapore 217562 For enquiries: WhatsApp 9067 0828 / 8870 8988 / 9170 2682 Email: enquiries@jiahe.com.sg Website: jiahe.com.sg eShop: https://shop.jiahe.com.sg For media enquiries, please contact: Ms Sharon VuVu Marcoms, engagevuMobile (65) 8138 6913Email: sharonvu@engagevusg.com
First and only contact force pulsed field ablation (PFA) system designed to transform treatment for millions with life-threatening ventricular arrhythmias. Preliminary data of VCAS study will be presented at HRS 2024 in Boston, Mass. CARDIFF-BY-THE-SEA, Calif., May 9, 2024 /PRNewswire/ -- Field Medical,™ Inc., a pioneer in pulsed field cardiac catheter ablation technology, today announced the initiation of its first-in-human study for the FieldForce™ Ablation System at Na Homolce Hospital in Prague, Czech Republic. The Ventricular Catheter Ablation Study, VCAS, will enroll up to 60 patients at up to 5 sites world-wide. The VCAS investigational study is a critical step towards demonstrating safety and performance of the FieldForce™ Ablation System, developed specifically to address the limitations of existing pulsed field ablation (PFA) and radiofrequency (RF) ablation systems, including a more time efficient treatment protocol for the treatment of ventricular arrhythmias. Preliminary results will be presented on May 16, 2024, at the Heart Rhythm Scientific Sessions in Boston, Mass. Field Medical’s FieldForce™ Catheter tip (A). The FieldBending™ technology utilizes an innovative internalized electrode within a fluid lumen seen in the cutaway (B). Voltage is delivered between the external and internal electrodes resulting in desirable electric field characteristics. The FieldForce™ Catheter is the first and only contact force PFA catheter optimized for the ventricles. "The FieldForce Ablation System, as the first contact force PFA system for ventricular ablation, is demonstrating significant promise early in our trials," said Vivek Reddy, MD, Director of Electrophysiology for the Mount Sinai Health System. "This is my first experience with a technology capable of achieving rapid complete transmural left ventricular (LV) ablation, offering highly targeted treatment options and an efficient workflow. Although these results are quite preliminary, the potential of this system to revolutionize catheter ablation of complex ventricular arrhythmias is profound, potentially surpassing the current standard of care. The scientific community will benefit from the comprehensive results from the completed study." PFA Adoption and Transition from Atrial to Ventricular Arrhythmias PFA has revolutionized the treatment of atrial fibrillation (AF) over the past decade, thanks to pioneering work by Field Medical CEO Steven Mickelsen, MD, founder of Farapulse which was subsequently acquired by Boston Scientific. His development of PFA technology marked a significant shift in cardiac electrophysiology, enhancing safety and reducing procedure times. This innovation set a new standard in the industry, leading to widespread adoption and the transformation of ablation practices. With PFA's proven success in atrial settings, Field Medical is now poised to extend these benefits to ventricular arrhythmias, signaling a pivotal evolution in the management of complex ventricular cardiac conditions. Ventricular Arrhythmia BurdenIt is estimated that ventricular arrhythmia impact over 6 million patients in the US and Europe. Ventricular arrhythmias, including ventricular tachycardia (VT) and premature ventricular contractions (PVCs), and pose a substantial risk, often leading to sudden cardiac death if not adequately managed. Current ventricular catheter ablation methods involve lengthy procedures and significant risks associated with thermal ablation, like conventional RF ablation. Field Medical's PFA technology aims to address these challenges by providing the first and only contact force PFA catheter optimized to work in the ventricle. This novel technology may enable predictable, time efficient, and safe treatment option. FieldBending™ takes advantage of non-intuitive physics to deliver intense, yet brief, electric fields designed to safely reduce procedure times dramatically. "Our vision at Field Medical is to transform VT ablation into a widely available, one-hour outpatient procedure with improved safety outcomes," said Steven Mickelsen MD, CEO of Field Medical. "With the promising early data for our VCAS study, in much the same way that PFA transformed AF, the FieldForce Ablation System is optimized to transform how ventricular arrhythmias are treated, offering hope to millions of patients worldwide. With the strong investor support, renown physician engagement and the groundbreaking potential of our technology, we are set to redefine the standards of cardiac ablation once again." About VCAS StudyField Medical's VCAS Study is a pivotal segment of a prospective safety and feasibility study, assessing the innovative FieldForce Ablation System in patients with ventricular arrhythmias. The VCAS-I group focuses on individuals suffering from ventricular tachycardia (VT), while the VCAS-II group targets those experiencing frequent premature ventricular complexes (PVCs). This study is instrumental in evaluating the performance of Pulsed Field Ablation (PFA), thereby potentially reducing procedural time compared to traditional Radiofrequency (RF) ablation. The trial aims to demonstrate that PFA can safely treat and improve overall outcomes for patients with challenging ventricular arrhythmias. For study information, visit clinicaltrials.gov NCT: NCT06203262. About Field Medical,™ Inc.Founded in 2022, Field Medical is at the forefront of developing second-generation pulsed field ablation (PFA) technologies, designed to meet the technical and safety challenges of modern cardiac ablation procedures. Under the leadership of Dr. Steven Mickelsen, CEO, a globally recognized expert in pulsed electric field technology, the company has pioneered the proprietary FieldBending™ technology. This innovation was developed to concentrate therapeutic effects and reduce unwanted far-field effects, with the potential to improve patient outcomes while simplifying the clinical experience for physicians. Field Medical focuses on expanding the applications of PFA beyond atrial fibrillation (AF) to address complex ventricular arrhythmias—a condition affecting over 6 million people in North America and Europe alone, often leading to sudden cardiac death, heart failure and significant clinical symptoms if not managed effectively. The company's comprehensive product portfolio, including the FieldForce™ Catheter, FieldForce™ Ablation System, and the FieldFlex™ Sheath, is specifically optimized to work in complex ventricular environments. For more information, visit www.fieldmedicalinc.com and follow us on LinkedIn and X. The FieldForce™ PFA Ablation System is an investigational device and is limited by Federal (or United States) Law to investigational use.
ARMONK, N.Y., May 9, 2024 /PRNewswire/ -- IBM (NYSE: IBM) today announced the availability of IBM Copilot Runway, a new offering from IBM Consulting designed to help enterprises create, customize, deploy and manage copilots including Copilot for Microsoft 365. With the new offering, clients will be able to seamlessly integrate copilots' generative AI into their organizations in order to enhance productivity and drive business success. IBM Consulting has also formed a dedicated practice of consultants with Microsoft copilot skills, credentials and expertise to guide clients on their AI transformation journey. IBM Corporation logo. As part of the new offering, IBM will work with clients to build custom copilots that can be tailored to fit the needs of specific business scenarios and efficiently deployed to help reduce the time and effort often required for implementations. IBM will initially focus on helping clients across priority use cases, including customer and field service, employee experience, and procurement and finance – as well as specific industries, like financial services, retail and CPG, government, and supply chain. These use cases will include: The Procurement and Finance Contract Copilot which assists specialists in extracting valuable insights from contracts. The Customer Service and Field Service Copilot which gives agents and technicians access to self-service options and a time-saving generative AI search. The Employee Experience Copilot which is designed to enhance employee engagement. IBM and Microsoft already serve clients across a variety of industries with a range of AI solutions and services. In fact, IBM Consulting worked with Virgin Money to develop and launch Redi, a conversational virtual assistant that helps credit card customers in the Virgin Money credit card app. Redi, powered by Virgin Money's suite of Microsoft Copilots, is a testament to the power of partnership. "Our customers tell us how much they enjoy interacting with Redi in the Credit Card app," said Adam Paice, Head of Digital Proposition, Virgin Money. "Our partnership with IBM has helped us to get the most out of Microsoft Copilot to find a balance between innovation and control." IBM Consulting is also scaling its Microsoft copilot capabilities and capacity across its network of Global Innovation Centers on each continent. For example, these capabilities are being used to co-create solutions with clients at IBM Consulting's new IBM-Microsoft Experience Zone in Bangalore, India – a first of its kind in our collaboration. At the Experience Zone, clients from around the world and across industries are working together with IBM Consulting in various technology stations to co-ideate and co-create generative AI-powered solutions – leveraging Microsoft technologies, including Copilot. Later this year, IBM Consulting plans to open additional IBM-Microsoft Experience Zones in Romania, U.K. and U.S., where clients in these regions can explore the power of Copilot. In addition IBM and Microsoft hosted a second client-focused hackathon with 800 participants, including clients and experts to build solutions leveraging Microsoft copilot – with winners to be announced this quarter. "As IBM and Microsoft strengthen our partnership, we're poised to empower more clients with Microsoft Copilot, supercharging productivity and boosting creativity through the power of generative AI," said John Granger, Senior Vice President, IBM Consulting. "Our dedicated IBM Consulting Microsoft practice, along with Copilot-focused Experience Zones around the world, help us meet clients where they are and bring them the right generative-AI-enabled solutions for their businesses." "Clients need the right partners and technology to scale AI responsibly across the enterprise," said Dinis Couto, General Manager of Global Partner Solutions for Microsoft. "With IBM's dedicated group of Microsoft Copilot experts, we're confident we can help more clients unlock the full potential of generative AI for their businesses." IBM purchased Copilot for Microsoft 365 for its practitioners. To continue building on the partnership, IBM has also invested in growing its team of experts and capabilities through acquisitions, like Neudesic and Bluetab. IBM Consulting practitioners work with a range of leading AI software technologies and multiple models from both IBM and its strategic partners like Microsoft. IBM data and AI consultants typically employ multiple models, each applied to a specific use case. Different models can be optimized for specific tasks, enhancing performance and efficiency. Microsoft is a trademark of Microsoft Corporation in the United States, other countries, or both. About IBMIBM is a leading provider of global hybrid cloud and AI, and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. More than 4,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM's hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM's breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM's long-standing commitment to trust, transparency, responsibility, inclusivity and service. Visit www.ibm.com for more information. Media Contact:IBMCarolyn BattCarolyn.Batt@ibm.com
MANILA, Philippines, May 9, 2024 /PRNewswire/ -- Globe, a leading telecommunications company in the Philippines, broadens the reach of the Hapag Movement, its advocacy to alleviate involuntary hunger, as it teams up with US-based non-profit Project PEARLS, opening up the program to a global audience. Individuals and corporations from around the United States may now donate to the Hapag Movement through Project PEARLS via https://givebutter.com/unitevshunger. Project PEARLS may issue companies and individuals required certificates for all donations received from around the US. This partnership expands the Hapag Movement's reach to the US, a critical donation funding source that is home to more than 4 million Filipino-Americans. Globe is calling on US-based individuals and businesses to support the cause of Hapag, the Tagalog word for "table" where everyone gathers to share meals. "Our partnership with Project PEARLS is a significant step forward that will allow us to engage a wider community of donors in our fight against hunger," said Yoly Crisanto, Globe's Chief Sustainability and Corporate Communications Officer. "With Project PEARLS' expansive network, we can accelerate positive change and help more Filipino families in need." The Hapag Movement leverages technology and partnerships to drive collective action for sustainable development while empowering partner organizations. Since its launch in 2022, it has provided over 95,000 Filipinos with food packs and produced 2,662 livelihood training graduates, with 2,361 of them going on to start their small businesses. "Joining forces with Globe is a dream come true for Project PEARLS," said Melissa Villa, Project PEARLS Founder and Executive Director. "It signifies a monumental shift towards leveraging Globe's technology to extend our reach and effectiveness." Founded in 2010, Project PEARLS is dedicated to ending poverty in the Philippines through education, empowerment, nutrition, nourishment, and healthcare initiatives. It supports communities in Metro Manila, Bulacan, Cavite, Zamboanga Sibugay, and Zambales through programs such as scholarships for over 700 students, daily meals, a health clinic, literacy clubs, and women's livelihood training. The Philippines continues to grapple with widespread hunger. According to the latest Social Weather Stations survey, 12.6% of Filipino families reported experiencing involuntary hunger in December 2023, rising from 9.8 percent in September of the same year. The Hapag Movement keeps gaining momentum in achieving key impact milestones. With Project PEARLS opening new avenues for international engagement, the movement progresses significantly toward its goal of uplifting underserved Filipino communities. To learn more about the Hapag Movement, please visit https://www.globe.com.ph/about-us/sustainability/globe-of-good#gref. ABOUT GLOBE Globe is a leading full-service telecommunications company in the Philippines and publicly listed in the PSE with the stock symbol GLO. The company serves the telecommunications and technology needs of consumers and businesses across an entire suite of products and services including mobile, fixed, broadband, data connectivity, internet and managed services. It has major interests in financial technology, digital marketing solutions, venture capital funding for startups, and virtual healthcare. In 2019, Globe became a signatory to the United Nations Global Compact, committing to implement universal sustainability principles. Its principals are Ayala Corporation and Singtel, acknowledged industry leaders in the country and in the region.
The latest innovation is anticipated to increase collection volume without increasing collection time Rika's individualized nomogram, iNomi, can enable plasma donors to donate the right amount of plasma on any given day based on height, weight and hematocrit. The Rika Plasma Donation System (Rika) is designed for donor comfort and safety. On average, it completes plasma collections in 35 minutes or less, ensures there is never more than 200 milliliters of blood outside the donor's body at one time and has an advanced control system to guide device operators. It can take 130 plasma donations to treat the annual needs of just one patient with a primary immune deficiency, according to the Plasma Protein Therapeutics Association.1 LAKEWOOD, Colo., May 9, 2024 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rika Plasma Donation System™ with the iNomi™ Nomogram. This innovation means that plasma collection volume can be determined by an individual donor's height, weight and hematocrit level on the day they donate plasma. The Rika Plasma Donation SystemTM (Rika) is designed for donor comfort and safety. On average, it completes plasma collections in 35 minutes or less, ensures there is never more than 200 milliliters of blood outside the donor's body at one time and has an advanced control system to guide device operators. Terumo BCT makes a broad suite of medical devices that collect, separate and process blood and cells. Rika is the next-generation plasma collection system designed and developed for use in plasma collection centers. "Terumo BCT continues to innovate for the plasma industry, setting new standards and expanding patient access to care," said Antoinette Gawin, President and Chief Executive Officer, Terumo Blood and Cell Technologies. "As the need for plasma increases, the Rika ecosystem, now including iNomi, is poised to help meet the demand while offering a potentially more comfortable and efficient experience for plasma donors." The individualized nomogram is anticipated to increase collection volume without increasing collection time. The clinical trial to support the recent FDA clearance showed an average 10% increase in the volume of plasma collected per donation with an average collection time of less than 35 minutes.2 The Terumo BCT team behind Rika focused on technology and the experiences of plasma donors and collection center employees. A collection time of 35 minutes or less, combined with volume of 200 milliliters or less of blood outside the donor's body, can mean a more comfortable donation experience. Rika's advanced control system enhances donor safety by monitoring the process and providing alerts and visual cues that guide the operator. Rika makes automatic adjustments during each procedure, enabling a more seamless operator experience and the ability to spend more time with the donor. "CSL Plasma looks forward to the rollout of the individualized nomogram as we continue to introduce the Rika Plasma Donation System to our close to 330 centers in the United States. We are eager to implement this latest innovation from Terumo that supports our dedication to our donors, employees and delivering on our promise to our patients," said Michelle Meyer, VP Plasma Global Operations, CSL Plasma. Representing a new era in plasma collections, Rika was cleared for use by the FDA in March 2022 as part of an extensive ecosystem including the MyataTM Customer Service Portal and the KinariTM Device Management Platform, which enables electronic software distribution. All this is anticipated to support center productivity and efficiency to optimize plasma collections and meet the needs of patients affected by life-threatening illnesses who rely on plasma-derived therapies. 1. https://www.pptaglobal.org/donate 2. Clinical data available on file at Terumo Blood and Cell Technologies About Terumo Blood and Cell Technologies Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today. This belief inspires our innovation and strengthens our collaboration with customers. Terumo Blood and Cell Technologies' customers include blood centers, hospitals, therapeutic apheresis clinics, cell collection and processing organizations, researchers and private medical practices. Our customers are based in over 150 countries across the globe. We have 750+ granted patents, with more than 150 additionally pending. We have global headquarters in Lakewood, Colo., U.S.A., along with five regional headquarters, seven manufacturing sites and six innovation and development centers across the globe. Terumo Blood and Cell Technologies is a subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology.
The annual event highlights success paths with Artificial Intelligence, Augmented Reality/Virtual Reality, and Robotics for the Southeast Asian region SINGAPORE and KUALA LUMPUR, Malaysia, May 9, 2024 /PRNewswire/ -- Rockwell Automation, the world's largest company dedicated to industrial automation and digital transformation, hosted its annual ROKLive Southeast Asia event in Kuala Lumpur, Malaysia. With the theme 'Discover What's Possible,' the event showcased the latest innovations in industrial technology such as Artificial Intelligence (AI), cloud-based manufacturing execution systems (MES), and cybersecurity, while addressing key challenges and trends in manufacturing. This year's ROKLive event served as a platform for customers and partners to dream big and present an opportunity to educate themselves on transformative technologies like AI, Augmented Reality/Virtual Reality (AR/VR), and robotics, discovering how these innovations can help revolutionize their business. The event featured engaging presentations, customer experience sharing, technology updates, industry-focus discussions, and an interactive expo featuring the latest innovations from Rockwell Automation and members of its PartnerNetwork™. Sustainability, cybersecurity, and emerging technologies in digital transformation were among the key points of discussion in the sessions. The event saw high-level knowledge sharing through keynote speeches and forums, where Marcelo Tarkieltaub, regional director, Southeast Asia for Rockwell Automation delivered a keynote on the future of automation, highlighting its potential for simplifying innovation, enhancing flexibility, and boosting performance in complex industrial settings. Apart from key executives and subject matter experts from Rockwell Automation, distinguished guests including The Honourable Fahmi Fadzil, Minister of Communications; The Honourable Tuan Dr. Mohammad Fahmi B. Ngah, Selangor State Minister for Islamic Affairs, Halal Industry, Digital Infrastructure and Technology Innovation; and Ms. Zakiah Sajidan, Director of Machinery and Metal Technology from the Malaysian Investment Development Authority (MIDA), offered invaluable insights through fireside chats during the conference. Speaking on the occasion, Marcelo said: "With the increasing number of transformative technologies in the market, it is important for business leaders to adapt to the evolving market landscape by leveraging innovative solutions and remain competitive within their industries." Amidst global challenges such as inflation and supply chain disruptions, the manufacturing industry is increasingly turning to technology to enhance productivity, address skilled labour shortages, and strengthen cybersecurity measures. The latest State of Smart Manufacturing Report by Rockwell Automation revealed a growing focus on AI and machine learning among manufacturers, with significant investments being made in automation and digitalization. Within the region, 48% of manufacturers are increasing automation within the business, with 44% starting to introduce AI and machine learning. The overall sales value of Malaysia's manufacturing sector reached RM1.8 trillion (429 billion USD) in 2023, according to the Department of Statistics Malaysia (DoSM) with an expected compound annual growth rate (CAGR) of 6.05% from 2024 to 2028. Coupled with the New Industrial Master Plan 2030 (NIMP 2030), designed to address domestic manufacturing challenges, Malaysia is well on its way to revitalizing its manufacturing sector. Adopting smart manufacturing can help businesses improve efficiency, increase capacity, reduce inventory, view processes and address production bottlenecks in real time — from sourcing, procurement, processing and manufacturing to distribution, warehousing, customer service and sales. As a part of NIMP 2030, the objective is to transform 3,000 smart factories, promoting a tech-forward culture and facilitating the development of high-skilled jobs in the manufacturing sector. "At the event this year, attendees experienced the transformative power of enterprise connectivity, delivering data-fuelled insights for informed, real-time decision-making for better outcomes. Malaysia, like many other countries, can benefit significantly from embracing smart manufacturing practices and emerging technologies. It is crucial for enterprises to embrace technology and digitalization to be more sustainable and boost productivity for economic growth", said Mariya Prempeh, country manager, Singapore, Malaysia and Brunei, Rockwell Automation. For over 40 years Rockwell Automation has been a significant presence in the Asia Pacific region, committed to its vision of expanding the possibilities for humans and driving digital transformation that achieves results for its customers. With a strong network of partners working together, Rockwell Automation is driving industry transformation through innovative automation and connected enterprise solutions. By unlocking the potential of its customers and improving productivity through technology, Rockwell Automation is continuously transforming the industry. For more information about ROKLive Kuala Lumpur, please visit the official website. About Rockwell Automation Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 29,000 problem solvers dedicated to our customers in more than 100 countries. To learn more about how we are bringing the Connected Enterprise to life across industrial enterprises, visit www.rockwellautomation.com.
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
